Joint Commission Accreditation Survey
DNA Ploidy
By using DNA Ploidy analysis, urologists may be better equipped to make bladder cancer treatment decisions.
DNA in conjunction with cytology provides a 75.3% sensitivity, 38% greater than cytology alone.
Bladder Cytology Patient Report
Click here to view a UroCor LabsSM Bladder Cytology Patient Report exclusive only to UroCor Labs
Bladder Cytology Physician Report
Click here to view a Bladder Cytology Physician Report exclusive only to UroCor LabsSM
Clinical Literature
Click here to learn more about DNA ploidy by exploring clinical literature from the accredited source below.
More Info/Rep Visit
DD23 Tumor Marker
